Minimal Hepatic Encephalopathy: Clinical Trials

20 trials for Minimal Hepatic Encephalopathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 4 not yet recruiting, 1 recruiting, 1 terminated. 6 Not applicable, 3 Phase 2, 3 Phase 4, 2 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable6Completed 3, Not yet recruiting 2, Unknown 1
Phase 23Completed 2, Terminated 1
Phase 43Completed 2, Recruiting 1
Phase 12Completed 2
Phase 31Withdrawn 1

Follow Minimal Hepatic Encephalopathy: new trials by email Literature Review of Minimal Hepatic Encephalopathy trials Research Report on Minimal Hepatic Encephalopathy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Electronic PHES vs Paper-based PHES for Hepatic Encephalopathy
Paper-based Psychometric Hepatic Encephalopathy Score (PHES), Electronic Psychometric Hepatic Encephalopathy Score (PHES) - Liver Cirrhosis, Hepatic Encephalopathy
Not applicableNot yet recruitingThe First Affiliated Hospital with Nanjing Medical University802026-10-012026-10-01
A Prospective Cohort Study on the Epidemiological Investigation, Diagnosis, and Treatment of Hepatic Encephalopathy
wechat mini-program - Hepatic Encephalopathy, Minimal Hepatic Encephalopathy
Not yet recruitingThe First Affiliated Hospital with Nanjing Medical University7002026-10-012026-10-01
Equivalence of Electronic vs Paper-based PHES in Diagnosing Hepatic Encephalopathy
Paper-based PHES, Electronic PHES - Liver Cirrhosis, Hepatic Encephalopathy (HE)
Not applicableNot yet recruitingThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School802026-10-012026-10-14
Psychometric Hepatic Encephalopathy Score in Prediction of Minimal Hepatic Encephalopathy in Compensated Cirrhotic Patients
Psychometric Hepatic Encephalopathy Score (PHES) - Minimal Hepatic Encephalopathy
Not yet recruitingSohag University1502025-12-012025-12-09
BCAA vs. Rifaximin in Patients With Cirrhosis for Secondary Prophylaxis of HE
Oral Branched chain Amino acid, Rifaximin 550 MG, Lactulose - Hepatic Encephalopathy, Decompensated Cirrhosis
Phase 4RecruitingPost Graduate Institute of Medical Education and Research, Chandigarh3362025-02-012025-06-10
Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility
Rifaximin - Cirrhosis, Liver, Minimal Hepatic Encephalopathy
Phase 3WithdrawnMetroHealth Medical Center2021-09-152025-12-24
A Study of MHE in Patients With Liver Diseases
neurophysiological tests, blood biomarkers. - Hepatic Encephalopathy, Minimal Hepatic Encephalopathy
CompletedQin Ning2522019-05-012024-06-17
HEAL STUDY (Hepatic Encephalopathy and Albumin Study)
25% IV albumin, Placebo - Cirrhosis, Hepatic Encephalopathy
Phase 2CompletedHunter Holmes Mcguire Veteran Affairs Medical Center482018-06-202022-05-31
Transcranial Doppler Ultrasound and Minimal Hepatic Encephalopathy
Rifaximin - Minimal Hepatic Encephalopathy
CompletedFondazione Policlinico Universitario Agostino Gemelli IRCCS1002018-01-182019-09-04
Reversibility of Minimal Hepatic Encephalopathy Following Liver Transplantation
Liver transplantation - Minimal Hepatic Encephalopathy
CompletedAin Shams University402014-06-012016-05-11
Brain Muscle Axis During Treatment of Hepatic Encephalopathy With L-ornithine L-aspartate
Vastus Muscle Biopsy, LOLA or placebo, Cognitive assessment (PHES) - Hepatic Encephalopathy, Minimal Hepatic Encephalopathy
Phase 4CompletedImperial College London422013-08-012015-10-22
Antioxidants and Zinc Improving Minimal Hepatic Encephalopathy In Truck Drivers; a Pilot Study
175 mg zinc gluconate, 50000 IU vitamin A, 500 mg vitamin C and 100 mg vitamin E once daily plus lactulose; dose 30-60 ml/day for 3 months, Lactulose - Minimal Hepatic Encephalopathy
CompletedMansoura University582013-01-012015-08-13
Hyperproteic Diet Plus Lactobacillus Reuteri and Nitazoxanide in Minimal Hepatic Encephalopathy
Auxiliary Treatment, Hyperproteic and fiber-rich diet, Nitazoxanide - Hepatic Cirrhosis, Minimal Hepatic Encephalopathy
Not applicableCompletedInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran602010-08-012014-08-20
Study of Rifaximin in Minimal Hepatic Encephalopathy
Rifaximin, rifaximin - Minimal Hepatic Encephalopathy
Phase 1 / Phase 2CompletedHunter Holmes Mcguire Veteran Affairs Medical Center202010-02-012012-12-11
Probiotic Lactobacillus GG (LGG) in Patients With Minimal Hepatic Encephalopathy
Lactobacillus GG, Placebo - Minimal Hepatic Encephalopathy
Phase 1CompletedVirginia Commonwealth University372009-10-012014-01-07
Study of Lactulose in Children With Chronic Liver Disease
Lactulose, placebo - Minimal Hepatic Encephalopathy
Phase 2TerminatedIndiana University162009-01-012014-02-10
A Nutritional Approach to Minimal Hepatic Encephalopathy
Nutritional Intervention - Minimal Hepatic Encephalopathy
Not applicableUnknownTel-Aviv Sourasky Medical Center602008-07-012010-03-09
Effect of Yogurt on Minimal Hepatic Encephalopathy
Yogurt Supplementation - Cirrhosis, Minimal Hepatic Encephalopathy
Not applicableCompletedMedical College of Wisconsin302005-11-012007-11-01
Effect of Lactulose on Minimal Hepatic Encephalopathy and Health-Related Quality of Life
Lactulose - Minimal Hepatic Encephalopathy, Hepatic Encephalopathy
Phase 4CompletedPost Graduate Institute of Medical Education and Research, Chandigarh802004-01-012007-03-02
Acetyl-L-Carnitine Reduces Depression and Improves Quality of Life in Patients With Minimal Hepatic Encephalopathy
Acetyl-L-Carnitine, placebo - Minimal Hepatic Encephalopathy
Not applicableCompletedUniversity of Catania672002-04-012010-10-19

Narrower conditions

Hepatic Encephalopathy (9)  ·  Liver Cirrhosis (6)  ·  Fibrosis (5)  ·  Brain Diseases (2)  ·  Acute-On-Chronic Liver Failure (1)  ·  Depression (1)  ·  Disease (1)  ·  Inflammation (1)

Broader conditions

Central Nervous System Diseases (11)  ·  Digestive System Diseases (11)  ·  Liver Diseases (11)  ·  Nervous System Diseases (11)  ·  Pathologic Processes (11)  ·  Pathological Conditions, Signs and Symptoms (11)  ·  Brain Diseases (9)  ·  Brain Diseases, Metabolic (9)  ·  Hepatic Insufficiency (9)  ·  Liver Failure (9)  ·  Metabolic Diseases (9)  ·  Nutritional and Metabolic Diseases (9)  ·  Fibrosis (6)  ·  Behavior (1)  ·  Behavioral Symptoms (1)

Interventions

Lactulose (4)  ·  Rifaximin (4)  ·  Acetylcarnitine (1)  ·  Albumins (1)  ·  Amino Acids, Branched-Chain (1)  ·  Ascorbic Acid (1)  ·  Blood Specimen Collection (1)  ·  Liver Transplantation (1)  ·  Nutrition Assessment (1)  ·  Probiotics (1)  ·  Spectrum Analysis (1)  ·  Vitamin A (1)  ·  gluconic acid (1)  ·  nitazoxanide (1)

Sponsors

Hunter Holmes Mcguire Veteran Affairs Medical Center (2)  ·  Post Graduate Institute of Medical Education and Research, Chandigarh (2)  ·  The First Affiliated Hospital with Nanjing Medical University (2)  ·  Ain Shams University (1)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)  ·  Imperial College London (1)  ·  Indiana University (1)  ·  Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (1)  ·  Mansoura University (1)  ·  Medical College of Wisconsin (1)  ·  MetroHealth Medical Center (1)  ·  Qin Ning (1)  ·  Sohag University (1)  ·  Tel-Aviv Sourasky Medical Center (1)  ·  The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (1)

Countries

United States (5)  ·  China (3)  ·  India (2)  ·  Italy (2)  ·  Egypt (1)  ·  Israel (1)  ·  Mexico (1)  ·  United Kingdom (1)

Top investigators

Jasmohan S Bajaj, MD, MSc (2)  ·  Aldo Torre-Delgadillo, MD (1)  ·  Girish Subbarao, M.D. (1)  ·  Jasmohan Bajaj, MD (1)  ·  Jasmohan S Bajaj, MD (1)  ·  Nachum Vaisman, Prof' (1)  ·  Qin Ning, MD., PhD. (1)  ·  Radha K Dhiman, MD,DM, FACG (1)  ·  Ronnie Fass, MD (1)  ·  Simon D Taylor-Robinson, MD FRCP (1)

Results publications

PMID 26644276, PMID 17326150, PMID 19302262, PMID 20444959, PMID 20675008, PMID 20849805, PMID 21157444, PMID 23565181, PMID 25932262, PMID 31701074, PMID 34233031, PMID 36152764, PMID 38108656, PMID 38349709, PMID 39015557, PMID 41773757

NIH funding

U01AT004428 (1)